Novavax ($NVAX) and Novartis ($NVS) have both been racing to bring to market a vaccine for the avian H7N9 flu, which has caused more than 130 infections and 43 deaths in China. But in the absence of an approved vaccine, researchers at Kansas State University think they’ve found an existing antiviral drug that could squelch […]
↧